BC
BCAX
Bicara Therapeutics Inc.
9.13
-6.17%
2026-10-30
Last 90d 2 insider sales
52-week range
8.36
30.99
1-month-49.8%
3-month-64.5%
1-year-42.5%
vs 50-day-53.7%
vs 200-day-56.9%
Volatility70%
Beta0.92
$ vol/day$24M
ATH30.99
From ATH-70.5%
Next report2026-11-10
Nothing written about BCAX yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 2mo | sched | 1 | $400,716 | 23.06 | |
| 3mo | sched | 3 | $1,153,874 | 24.51 | |
| 4mo | sched | 1 | $284,198 | 28.11 | |
| 4mo | sched | 2 | $1,640,801 | 28.80 | |
| 5mo | sched | 1 | $187,864 | 21.85 | |
| 5mo | sched | 1 | $300,561 | 20.46 | |
| 6mo | sched | 1 | $253,625 | 20.06 | |
| 6mo | sched | 1 | $125,840 | 22.29 | |
| 6mo | sched | 1 | $211,600 | 23.31 | |
| 6mo | sched | 1 | $354,150 | 23.63 | |
| 7mo | sched | 1 | $287,625 | 23.99 | |
| 7mo | sched | 1 | $104,225 | 18.70 | |
| 7mo | sched | 1 | $170,384 | 18.12 | |
| 7mo | sched | 1 | $282,361 | 18.70 | |
| 8mo | sched | 1 | $245,750 | 19.13 | |
| 8mo | sched | 1 | $704,804 | 19.97 | |
| 8mo | sched | 1 | $154,317 | 18.47 | |
| 8mo | sched | 3 | $922,452 | 18.27 | |
| 8mo | buy | 1 | $40,000,000 | 16.87 | |
| 8mo | sched | 1 | $65,503 | 16.59 | |
| 9mo | sched | 2 | $103,445 | 16.55 | |
| 9mo | sched | 1 | $2,685 | 16.46 | |
| 10mo | sched | 1 | $168,452 | 17.96 | |
| 11mo | sched | 1 | $233,500 | 18.18 | |
| 11mo | sched | 4 | $1,548,132 | 18.77 | |
| 1.0y | sched | 1 | $453,859 | 15.80 | |
| 1.0y | sched | 1 | $227,000 | 18.84 | |
| 1.0y | sched | 1 | $466,904 | 18.06 | |
| 1.1y | sched | 2 | $522,845 | 17.96 | |
| 1.1y | sched | 2 | $1,465,263 | 18.03 | |
| 1.1y | sched | 1 | $498,653 | 16.46 | |
| 1.1y | sched | 1 | $181,875 | 11.18 | |
| 1.4y | sched | 1 | $165,096 | 9.56 | |
| 1.6y | sched | 1 | $1,021,204 | 12.90 | |
| 2.1y | buy | 1 | $32,994,000 | 26.13 | |
| 2.1y | buy | 1 | $1,260,000 | 26.00 |
Next report 2026-11-10 (Tuesday, before open, in 8 days) · EPS estimate -0.82. It has finished the next session higher 50% of the time, average move 5.8%.
Day-after move, last 8 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | beat | -0.83 | -0.82 | +0.7% | -17.8% | -14.3% | -10.1% |
| 2026-05-11 | miss | -0.65 | -0.93 | -42.6% | -0.4% | +1.5% | -14.6% |
| 2026-03-30 | miss | -0.65 | -0.68 | -4.0% | +4.1% | +3.6% | +15.9% |
| 2025-11-10 | miss | -0.53 | -0.67 | -25.5% | +1.0% | -4.8% | +2.8% |
| 2025-08-12 | beat | -0.54 | -0.50 | +6.8% | -2.6% | +4.8% | +15.2% |
| 2025-05-13 | miss | -0.40 | -0.68 | -70.8% | +0.0% | -8.1% | +6.0% |
| 2025-03-27 | miss | -0.28 | -0.39 | -38.0% | +1.2% | +2.3% | -9.7% |
| 2024-11-12 | miss | -0.50 | -1.60 | -220.0% | -0.8% | -7.3% | -19.9% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
+0.6%
Next 1 month
+2.2%
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.25%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 0.92 +2.2%
$24M/day volume
70% volatility
-42% 1-year
-70% from ATH
52-week range · 3% of the way up · -70% from the high
$8.36$30.99
Not investment advice.
Continue with Google